Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 9/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.43 |
| ▸ | SCD5 | Q86SK9 | 2/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3865150 | 1.00 | HSD11B1 (0.57) | HSD11B1POLBTDP1HSD17B1SCD5 | |
| SCHEMBL13124915 | 0.90 | HSD11B1 (0.61) | HSD11B1POLBTDP1HSD17B1SCD5 | |
| SCHEMBL3792411 | 0.86 | HSD11B1 (0.58) | HSD11B1POLBTDP1HSD17B1SCD5 | |
| SCHEMBL13124826 | 0.86 | HSD11B1 (0.58) | HSD11B1POLBTDP1HSD17B1SCD5 | |
| SCHEMBL13124789 | 0.86 | HSD11B1 (0.69) | HSD11B1POLBTDP1HSD17B1SCD5 | |
| SCHEMBL13124712 | 0.86 | HSD11B1 (0.63) | HSD11B1POLBTDP1HSD17B1SCD5 | |
| SCHEMBL3719418 | 0.85 | HSD11B1 (0.57) | HSD11B1POLBTDP1HSD17B1SCD5 | |
| SCHEMBL3793178 | 0.85 | HSD11B1 (0.63) | HSD11B1POLBTDP1HSD17B1CNR2 | |
| SCHEMBL3793175 | 0.85 | HSD11B1 (0.63) | HSD11B1POLBTDP1HSD17B1CNR2 | |
| SCHEMBL3719420 | 0.85 | HSD11B1 (0.57) | HSD11B1POLBTDP1HSD17B1SCD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362008-B2 | Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors | THE UNIVERSITY OF EDINBURGH (GB) | 2013-01-29 | — | — | US | disclosed |
| US-20100267696-A1 | Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors | THE UNIVERSITY OF EDINBURGH | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267696-A1 | Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors | HSD11B1, HSD11B2, HSD17B1 | HSD11B1 1/4885POLB 3451/4885TDP1 643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.